Citius Pharmaceuticals Inc (CTXR) Stock Price & News - Google Finance (2024)

Markets

US

Europe

Asia

Currencies

Crypto

Futures

Dow Jones40,687.91+0.37%+147.98Dow Jones40,687.910.37%
Nasdaq17,284.05-0.50%-86.15Nasdaq17,284.050.50%
Russell2,241.90+0.29%+6.57Russell2,241.900.29%
VIX16.73+0.78%+0.13VIX16.730.78%

HomeCTXR • NASDAQ

Citius Pharmaceuticals Inc

$0.98

Jul 30, 10:38:32 AM GMT-4 · USD · NASDAQ · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

American Battery Technology Co

$1.00

ABAT0.99%

Biora Therapeutics Inc

$0.68

BIOR0.94%

BioNano Genomics Inc

$0.63

BNGO0.047%

Checkpoint Therapeutics Inc

$2.34

CKPT3.31%

Maxeon Solar Technologies Ltd

$0.19

MAXN3.79%

Seres Therapeutics Inc

$1.39

MCRB2.80%

Geron Corp

$4.70

GERN0.11%

FibroGen Inc

$1.10

FGEN2.23%

Eyenovia Inc

$1.30

EYEN5.10%

Amarin Corporation plc

$0.78

AMRN0.50%

Market news

Financials

Income Statement

Revenue

Net income

(USD)Mar 2024info

Fiscal Q2 2024 ended 3/31/24.

Y/Y change

Revenue

The total amount of income generated by the sale of goods or services related to the company's primary operations

Operating expense

Represents the total incurred expenses through normal operations

10.97M2.67%

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-8.54M18.83%

Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.

-0.0528.57%

EBITDA

Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances

-10.97M-2.67%

Effective tax rate

The percent of their income that a corporation pays in taxes

-1.71%

Total assets

Total liabilities

(USD)Mar 2024info

Fiscal Q2 2024 ended 3/31/24.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year

12.56M-56.79%

Total assets

The total amount of assets owned by a company

90.71M-12.98%

Total liabilities

Sum of the combined debts a company owes

10.74M-13.59%

Total equity

The value of subtracting the total liabilities from the total assets of a company

79.97M

Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing

180.67M

Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock

1.97

Return on assets

A financial ratio that shows a company’s profitability compared to its assets

-29.16%

Return on capital

Company’s return above the average cost it pays for its debt and equity capital

-33.02%

Net change in cash

(USD)Mar 2024info

Fiscal Q2 2024 ended 3/31/24.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-8.54M18.83%

Cash from operations

Net cash used or generated for core business activities

-7.79M0.85%

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

-7.79M0.46%

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments

-6.19M-47.25%

Stock

Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned

US listed security

Listed on NASDAQ

US headquartered

Headquartered in Cranford, New Jersey, United States

Previous close

The last closing price

$0.99

Day range

The range between the high and low prices over the past day

$0.96 - $1.00

Year range

The range between the high and low prices over the past 52 weeks

$0.48 - $1.07

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

176.58M USD

Avg Volume

The average number of shares traded each day over the past 30 days

2.74M

P/E ratio

The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks

-

Dividend yield

The ratio of annual dividend to current share price that estimates the dividend return of a stock

-

Primary exchange

Listed exchange for this security

NASDAQ

About

Founded

2007

Headquarters

Cranford, New JerseyUnited States

Employees

22

Discover more

You may be interested in

info

This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexTA-35 Index2,005.020.79%
IndexDow Jones Industrial Average40,687.910.37%
IndexNasdaq-10018,972.450.46%
TSLATesla Inc$230.320.77%
IndexTA-125 Index1,994.340.85%
AAPLApple Inc$218.710.21%
IndexVIX16.730.78%
AMZNAmazon.com Inc$183.540.19%
INTCIntel Corp$30.560.89%
IndexNasdaq Composite17,284.050.50%
BABAAlibaba Group Holding Ltd - ADR$78.460.20%
WIXWix.Com Ltd$155.870.083%
BABoeing Co$186.550.60%
METAMeta Platforms Inc$466.730.22%
MSFTMicrosoft Corp$425.550.28%
NFLXNetflix Inc$629.550.41%
NVDANVIDIA Corp$106.954.16%

People also search for

ABATAmerican Battery Technology Co$1.000.99%
BIORBiora Therapeutics Inc$0.680.94%
BNGOBioNano Genomics Inc$0.630.047%
CKPTCheckpoint Therapeutics Inc$2.343.31%
MAXNMaxeon Solar Technologies Ltd$0.193.79%
MCRBSeres Therapeutics Inc$1.392.80%
GERNGeron Corp$4.700.11%
FGENFibroGen Inc$1.102.23%
EYENEyenovia Inc$1.305.10%
AMRNAmarin Corporation plc$0.780.50%
ALLKAllakos Inc$0.922.18%
DRRXDURECT Corp$1.640.30%
ZOMZomedica Corp$0.150.067%
AEMDAethlon Medical, Inc.$0.380.71%
PSNYPolestar Automotive Holding Uk Plc$0.741.86%
QUBTQuantum Computing Inc$0.693.46%
BLRXBioLine RX Ltd - ADR$0.770.34%
AKBAAkebia Therapeutics Inc$1.381.79%

Citius Pharmaceuticals Inc (CTXR) Stock Price & News - Google Finance (7)HelpSend feedbackPrivacyTermsDisclaimer

Citius Pharmaceuticals Inc (CTXR) Stock Price & News - Google Finance (2024)

FAQs

What is the prediction for CTXR? ›

CTXR Stock 12 Month Forecast

Based on 3 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals in the last 3 months. The average price target is $4.67 with a high forecast of $6.00 and a low forecast of $4.00. The average price target represents a 386.46% change from the last price of $0.96.

What is the stock market forecast for CTXR in 2024? ›

According to our current CTXR stock forecast, the value of Citius Pharmaceuticals shares will drop by -3.82% and reach $ 0.76159 per share by July 25, 2024.

What is the price prediction for Citius? ›

Based on short-term price targets offered by two analysts, the average price target for Citius Pharmaceuticals, Inc. comes to $5.00. The forecasts range from a low of $4.00 to a high of $6.00. The average price target represents an increase of 437.63% from the last closing price of $0.93.

Who are CTXR competitors? ›

Who are the competitors of Citius Pharmaceuticals Inc (CTXR)?
CompanyMarket Cap($ Mln)
Charles River Laboratories (CRL)1,044
Qiagen N.V. - ADR910
Vaxcyte (PCVX)881
Legend Biotech Corp (LEGN)863

Is Citius Pharmaceuticals a buy? ›

Citius Pharmaceuticals has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

What is the price prediction for CTX in 2030? ›

The Cryptex Finance price prediction for 2030 is between $ 6.63 on the lower end and $ 10.75 on the high end. Based on our CTX price prediction chart, the price of Cryptex Finance could gain 318.06% and reach $ 10.75 if it reaches the upper price target.

Which stock will boom in 2024? ›

Top Long Term Stocks to Buy in 2024 Based on 5Y Avg Net Profit Margin
NameSub-SectorClose Price (Rs.)
Central Depository Services (India) LtdStock Exchanges & Ratings2,387.00
Aptus Value Housing Finance India LtdHome Financing337.00
SJVN LtdRenewable Energy131.00
Sun Tv Network LtdTV Channels & Broadcasters783.90
6 more rows
Jul 22, 2024

What are the 10 best stocks to buy right now? ›

Sign up for Kiplinger's Free E-Newsletters
Company (ticker)Analysts' consensus recommendation scoreAnalysts' consensus recommendation
ServiceNow (NOW)1.49Strong Buy
Assurant (AIZ)1.50Strong Buy
Howmet Aerospace (HWM)1.50Strong Buy
Insulet (PODD)1.50Strong Buy
21 more rows

Which stocks to buy for 6 months? ›

Highest returns in six months
S.No.NameP/E
1.Ujaas Energy82.73
2.Spright Agro217.48
3.Diamond Power385.98
4.Technvision Ven.178.90
23 more rows

What is the price prediction for CTX 2025? ›

In 2025, our analysis predicts Cryptex Finance to be traded between a low of $2.85 and a high of $8.32. Furthermore, with the analysis of market sentiment, we project an average trading price for CTX at approximately $2.93 in 2025.

What will be the price of Link in 2025? ›

Chainlink (LINK) Price Prediction 2030
YearPrice
2024$ 13.56
2025$ 14.24
2026$ 14.95
2027$ 15.70
1 more row

What is the keep price prediction 2025? ›

Long-term Keep Network price prediction for 2025, 2026, 2027, 2028, 2029 and 2030
YearYearly LowYearly High
2025$ 0.017756$ 0.475944
2026$ 0.005619$ 0.303639
2027-$ 0.03$ 0.040839
2028-$ 0.02$ 0.049454
2 more rows

What is the price target for CTXR stock? ›

Stock Price Targets
High$6.00
Median$4.00
Low$4.00
Average$4.67
Current Price$0.9309

Who are Mallinckrodt Pharmaceuticals competitors? ›

Similar companies to Mallinckrodt Pharmaceuticals
  • AbbVie. 54K $1B.
  • Allergan. 12K $1B.
  • Sanofi. 86K $1B.
  • Novartis. 75K $1B.
  • Pfizer. 102K $1B.
  • Roche. 95K $1B.
  • Johnson & Johnson. 103K $1B.
  • AstraZeneca. 71K $1B.

Who are true manufacturing competitors? ›

Similar companies to True Manufacturing
  • Scotsman Ice Systems. 235 $50M$100M.
  • Ice-O-Matic. 113 $10M$50M.
  • Electro Freeze. $10M.
  • Thermo Fisher Scientific. 94K $1B.
  • Thermo King. 2.3K $1B.
  • Hillphoenix. 1.1K $100M$1B.
  • Beverage-Air.
  • Carrier. 19K $100M$1B.

How high will Catalyst Pharmaceuticals stock go? ›

Average Price Target

Based on 5 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. The average price target is $27.33 with a high forecast of $29.00 and a low forecast of $26.00.

What is the forecast for align stock in 2025? ›

Align Technology Stock Prediction 2025

The Align Technology stock prediction for 2025 is currently $ 307.55, assuming that Align Technology shares will continue growing at the average yearly rate as they did in the last 10 years.

What is the target for Vertex Pharmaceuticals stock? ›

Stock Price Targets
High$589.00
Median$500.00
Low$325.00
Average$490.75
Current Price$492.26

Does CTXR pay dividends? ›

Citius Pharmaceuticals (NASDAQ: CTXR) does not pay a dividend.

Top Articles
Latest Posts
Article information

Author: Jamar Nader

Last Updated:

Views: 6255

Rating: 4.4 / 5 (75 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Jamar Nader

Birthday: 1995-02-28

Address: Apt. 536 6162 Reichel Greens, Port Zackaryside, CT 22682-9804

Phone: +9958384818317

Job: IT Representative

Hobby: Scrapbooking, Hiking, Hunting, Kite flying, Blacksmithing, Video gaming, Foraging

Introduction: My name is Jamar Nader, I am a fine, shiny, colorful, bright, nice, perfect, curious person who loves writing and wants to share my knowledge and understanding with you.